These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22574425)

  • 1. [Major changes in the global pharmaceutical industry].
    Hedner T; Thornblad T; Edgar B; Cowlrick I; Olausson M; Lind L; Klofsten M
    Lakartidningen; 2012 Feb 15-21; 109(7):324-5. PubMed ID: 22574425
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 3. Rewarding innovation in drug discovery.
    Lopes G
    Health Aff (Millwood); 2009; 28(3):922-3. PubMed ID: 19414906
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biopharmaceutical industry's commitment to innovation and to the future of health care].
    Marini G
    Recenti Prog Med; 2006 Nov; 97(11):626-33. PubMed ID: 17252719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to revive breakthrough innovation in the pharmaceutical industry.
    Munos BH; Chin WW
    Sci Transl Med; 2011 Jun; 3(89):89cm16. PubMed ID: 21715677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open Innovation in Drug Discovery research comes of age.
    Judd DB
    Drug Discov Today; 2013 Apr; 18(7-8):315-7. PubMed ID: 23220636
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug discovery in the next decade: innovation needed ASAP.
    Bennani YL
    Drug Discov Today; 2011 Sep; 16(17-18):779-92. PubMed ID: 21704185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global health needs to fill the innovation gap.
    Mundel T
    Nat Med; 2012 Dec; 18(12):1735. PubMed ID: 23223055
    [No Abstract]   [Full Text] [Related]  

  • 9. How to handle an industry in disruption: Intervene or laissez-faire?
    Munos B
    Sci Transl Med; 2015 May; 7(286):286ps12. PubMed ID: 25947160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 11. Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology.
    van der Greef J; McBurney RN
    Nat Rev Drug Discov; 2005 Dec; 4(12):961-7. PubMed ID: 16341061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What should embrace a national therapeutic drug strategy?].
    Furängen A; Cronlund A
    Lakartidningen; 2010 Jun 2-8; 107(22):1486-7; discussion 1487. PubMed ID: 20645603
    [No Abstract]   [Full Text] [Related]  

  • 13. Back to the future: driving innovation in drug development.
    Wagner JA
    Clin Pharmacol Ther; 2008 Feb; 83(2):199-202. PubMed ID: 18202681
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical innovation at the crossroads.
    Laubach GD; Gelijns AC
    Issues Sci Technol; 1995; 11(3):33-40. PubMed ID: 10141894
    [No Abstract]   [Full Text] [Related]  

  • 15. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creativity, innovation and lean sigma: a controversial combination?
    Johnstone C; Pairaudeau G; Pettersson JA
    Drug Discov Today; 2011 Jan; 16(1-2):50-7. PubMed ID: 21094693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Europe caught in innovation quagmire.
    Mitchell P
    Nat Biotechnol; 2005 Sep; 23(9):1029. PubMed ID: 16151378
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical innovation in the United States. Factors affecting future performance.
    Pollard MR
    Int J Technol Assess Health Care; 1993; 9(2):167-73. PubMed ID: 8458697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can open-source drug R&D repower pharmaceutical innovation?
    Munos B
    Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
    Doran E; Alexander Henry D
    J Public Health Policy; 2008 Apr; 29(1):106-20. PubMed ID: 18368023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.